The success of Pluvicto has created a new challenge in prostate cancer, one the field has not yet fully named or defined.
The post What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape appeared first on MedCity News.
Employer groups, unions urge Trump administration to reform No Surprises dispute resolution
Providers are reaping high award amounts, and arbiters have “structural conflicts of interest” that incentivize a high volume of disputes, driving up healthcare costs for
